Lexaria Bioscience Corp.·4

Apr 27, 5:13 PM ET

BUNKA CHRISTOPHER 4

4 · Lexaria Bioscience Corp. · Filed Apr 27, 2021

Insider Transaction Report

Form 4
Period: 2021-04-26
BUNKA CHRISTOPHER
DirectorChariman/CEO/President/CFO
Transactions
  • Award

    Stock Options

    2021-04-26+26,00056,001 total
    Exercise: $5.83From: 2021-04-26Exp: 2026-04-26Common Shares (26,000 underlying)
Holdings
  • Stock Options

    Exercise: $10.20From: 2020-04-23Exp: 2025-04-23Common Shares (23,334 underlying)
    30,001
  • common shares

    (indirect: Private Holding Company)
    215,912
  • common shares

    273,543
  • Warrants

    (indirect: Private Holding Company)
    Exercise: $10.50From: 2020-05-06Exp: 2025-05-06Common Shares (6,667 underlying)
    6,667

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT